Distinguished professor Dr. Tony Mikos of Rice University is coming to CHBE to give a seminar as part of our Speaker Series. The Seminar will take place on Monday, January 20, between 12:00 – 1:00pm, in CHBE Room 202. All are welcome to attend.
Biomaterials for Tissue Engineering
Biomaterial-based strategies for tissue engineering span a vast spectrum from the production of scaffolds tailored with appropriate mechanical properties and degradation kinetics to serve transiently as a bridge to tissue formation to the leverage of biomaterials for the controlled delivery of biological signals to regenerate tissue in specific sites in the body. For example, our laboratory has developed a variety of biodegradable polymers for the controlled delivery of bioactive agents and/or stem cell populations to promote regeneration of tissues such as bone and cartilage. We have also applied engineered culture of cell populations on three-dimensional scaffolds toward the development of biologically active hybrid scaffold/extracellular matrix constructs for regenerative medicine applications as well as testing of anticancer drugs. This talk will present recent examples of biomaterial-based approaches for the development of tissue engineering technologies to meet clinical needs.
ABOUT THE SPEAKER
Antonios G. Mikos is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He is the Director of the J.W. Cox Laboratory for Biomedical Engineering and the Director of the Center for Excellence in Tissue Engineering at Rice University. He received his Dipl.Eng. (1983) from the Aristotle University of Thessaloniki, Greece, and his Ph.D. (1988) in chemical engineering from Purdue University. He was a postdoctoral researcher at the Massachusetts Institute of Technology and the Harvard Medical School before joining the Rice Faculty in 1992 as an assistant professor.
Mikos’ research focuses on the synthesis, processing, and evaluation of new biomaterials for use as scaffolds for tissue engineering, as carriers for controlled drug delivery, and as non-viral vectors for gene therapy. His work has led to the development of novel orthopaedic, dental, cardiovascular, neurologic, and ophthalmologic biomaterials. He is the author of over 500 publications and 25 patents. He is the editor of 15 books and the author of one textbook (Biomaterials: The Intersection of Biology and Materials Science, Pearson Prentice Hall, 2008). He has been cited over 40,000 times and has an h-index of 109.